Genetic Evidence Linking SAP, the X-Linked Lymphoproliferative Gene Product, to Src-Related Kinase FynT in TH2 Cytokine Regulation  by Davidson, Dominique et al.
Immunity, Vol. 21, 707–717, November, 2004, Copyright 2004 by Cell Press
Genetic Evidence Linking SAP, the X-Linked
Lymphoproliferative Gene Product, to Src-Related
Kinase FynT in TH2 Cytokine Regulation
Whereas the precise pathophysiology of XLP has been
difficult to establish, studies using sap mice revealed
that SAP deficiency leads to reduced CD4 T cell helper
2 (TH2) functions in vitro, in particular T cell antigen
receptor (TCR)-induced IL-4 and IL-13 production (Wu
Dominique Davidson,1 Xiaochu Shi,1 Shaohua Zhang,1
Hao Wang,2 Mona Nemer,2,4,5 Nobuyuki Ono,6
Shinji Ohno,6 Yusuke Yanagi,6 and Andre´ Veillette1,3,4,5,*
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Clinical Research Institute of Montreal et al., 2001; Crotty et al., 2003; Czar et al., 2001; Yin et
al., 2003). These defects result in immunoglobulin (Ig)Montre´al, Que´bec H2W 1R7
Canada deficiency and a reduction of memory B cells. Increased
TH1 function and decreased CD8 T cell-dependent anti-3 Departments of Microbiology and Immunology
4 Department of Medicine viral responses were also identified in sap animals.
Through its SH2 domain, SAP associates with tyro-McGill University
Montre´al, Que´bec H3G 1Y6 sines in the cytoplasmic domain of signaling lymphocyte
activation molecule (SLAM) family receptors (VeilletteCanada
5 Department of Medicine and Latour, 2003; Engel et al., 2003; Veillette, 2004). This
receptor family includes SLAM, 2B4, Ly-9, CD84, NK-University of Montre´al
Montre´al, Que´bec H3C 3J7 T-B antigen (NTB-A)/Ly-108 and CD2-like receptor acti-
vating cytotoxic cells (CRACC). Although the functionCanada
6 Department of Virology of most of these receptors is not elucidated, character-
ization of slam/ mice showed that, like SAP, SLAMFaculty of Medicine
Kyushu University promotes IL-4 production by activated T cells (Wang et
al., 2004).Fukuoka 812-8582
Japan We previously proposed that SAP is critical for SLAM-
like receptor functions as a result of its capacity to en-
able tyrosine phosphorylation signaling by these recep-
tors (Veillette and Latour, 2003; Engel et al., 2003). ThisSummary
effect correlates with the aptitude of SAP to associate
selectively with the Src-related protein tyrosine kinaseSAP is an adaptor mutated in X-linked lymphoprolifer-
ative disease. It plays a critical role in T helper 2 (TH2) (PTK) FynT (Latour et al., 2001). Biochemical and crystal-
lographic data demonstrated that SAP interacts withcytokine production. This function was suggested to
reflect the capacity of SAP to associate with SLAM FynT via a second binding surface within the SAP SH2
domain and via the FynT SH3 domain (Latour et al.,family receptors and enable tyrosine phosphorylation
signaling by these receptors through SAP-mediated 2003; Chan et al., 2003). The binding region in SAP is
centered on arginine 78 (R78), which is opposite therecruitment of Src-related kinase FynT. Here, we
addressed by genetic means the importance of the phosphotyrosine binding fold of the SH2 domain. This
feature enables a single SAP molecule to bind SLAM andSAP-FynT interaction in normal T cell functions. By
creating a mouse in which the FynT binding site of FynT simultaneously. Such an activity was postulated to
be crucial for SAP function as a mutant in which R78SAP was inactivated in the germ line (sapR78A mouse)
and by analyzing mice lacking SAP, FynT or SLAM, was replaced by alanine was incapable of recruiting
FynT and promoting SLAM-like receptor-induced pro-evidence was obtained that the SAP-FynT cascade is
indeed crucial for normal TH2 functions in vitro and tein tyrosine phosphorylation in a T cell line (Latour et
al., 2003; Chen et al., 2004).in vivo. These data imply that SAP is necessary for TH2
cytokine regulation primarily as a result of its capacity Here, we wanted to determine the functional impor-
tance of the SAP-FynT interaction during TH2 cytokineto recruit FynT. They also establish a previously unap-
preciated role for FynT in SAP-dependent TH2 cyto- regulation in normal T cells. By analyzing mice lacking
SAP, FynT or SLAM, and by engineering mice in whichkine regulation.
SAP R78 is mutated in the germ line, we obtained firm
genetic evidence that the SLAM-SAP-FynT cascade isIntroduction
pivotal in TH2 cytokine production.
SAP (also named SH2D1A) is composed of an Src ho-
mology 2 (SH2) domain and a short carboxyl-terminal tail Results
of unknown function (Latour and Veillette, 2003; Engel et
al., 2003). It is expressed in T cells, natural killer (NK) fyn/ T Cells Have Global TCR-Induced
cells and, possibly, B cells. The sap gene is mutated Activation Defects
or deleted in X-linked lymphoproliferation (XLP), a fatal If FynT were to play a critical and specific role in SAP-
human immune dysfunction characterized by a dereg- mediated functions, one would expect that the TH2 de-
ulated response to Epstein-Barr virus (EBV) infection, fects observed in sap T cells would exist in fyn/
hypogammaglobulinemia and malignant lymphomas. T cells. Along these lines, fyn/ T cells display reduced
proliferation and IL-2 secretion in response to anti-CD3
antibodies (anti-CD3) plus phorbol myristate acetate*Correspondence: veillea@ircm.qc.ca
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Figure 1. TCR-Mediated Responses in fyn/ and sap T Cells
(A–D) Comparison of fyn/ and fyn/ T cells. Purified CD4 T cells were stimulated with the indicated concentrations of anti-CD3 alone or
in combination with anti-CD28. After 48 hr, cytokine production (A–C) was determined by ELISA, whereas proliferation (D) was monitored by
measuring tritiated thymidine incorporation. Assays were done in duplicate and repeated at least five times. Error bars are shown.
(E–G) Comparison of fyn/ and sap T cells. CD4 T cells were stimulated with anti-CD3 with or without anti-CD28, in the presence of
exogenous IL-2 (100 U ml1 ). Cytokine production (E and F) and proliferation (G) were assessed as for Figures 1A–1D.
(H) Expression of FynT and SAP. Purified CD4 T cells were lysed, and the abundance of FynT (top), SAP (middle), and Lck (bottom) was
ascertained by immunoblotting total cellular proteins with anti-FynT, anti-SAP and anti-Lck, respectively.
(PMA) (Appleby et al., 1992; Stein et al., 1992). Unfortu- However, contrary to fyn/T cells, no reduction of IFN-
production (Figure 1E) or T cell proliferation (Figure 1G)nately, few additional analyses have been performed on
fyn/ T cells. In the light of this, the impact of FynT was seen in sap T cells. In some experiments, a small
increase in IFN- release was actually observed (Figuredeficiency on TCR-mediated responses was reexam-
ined (Figure 1). 1E). Thus, FynT deficiency yielded pronounced activa-
tion defects involving TH2 and, to a lesser extent, TH1CD4 T cells from fyn/ and fyn/ mice were stimu-
lated with anti-CD3 alone or in combination with anti- cytokines, whereas SAP deficiency led to a more selec-
tive deficit implicating TH2 cytokines.CD28. After 48 hr, cytokine production (Figures 1A–1C)
and proliferation (Figure 1D) were determined. Com-
pared to wild-type T cells, fyn/ T cells had pronounced Generation of sapR78A Knockin Mice
While these data were consistent with the idea that SAPdefects in TCR-initiated proliferation (Figure 1D), and
production of IFN- (Figure 1A), IL-4 (Figure 1B), and is utilizing FynT for TH2 priming, this interpretation was
complicated by the fact that the defects in fyn/ T cellsIL-2 (Figure 1C). Some of these responses, in particular
IFN- secretion and proliferation, were partially cor- were more severe than those in sap T cells. To address
more clearly the role of FynT in SAP function, we createdrected by addition of exogenous IL-2 (Figures 1E–1G;
Supplemental Table S1, available online at http://www. a mouse in which the FynT binding site of SAP, R78,
was replaced by an alanine in the germ line. This knockinimmunity.com/cgi/content/full/21/5/707/DC1/). How-
ever, the block in IL-4 was not relieved (Figure 1F). mutation was expected to preserve the capacity of SAP
to associate with SLAM receptors, while eliminating itsThese defects were compared to those seen in sap
T cells (Figures 1E–1G). In agreement with earlier reports ability to recruit FynT. After transfection of embryonic
stem (ES) cells with the DNA construct depicted in Figure(Wu et al., 2001; Czar et al., 2001), CD4 T cells from
sap mice demonstrated a defect in IL-4 production 2A, ES cells showing evidence of homologous recombi-
nation were identified. Mice carrying the sapR78A mutation(Figure 1F). As was the case for fyn/ T cells, this deficit
was not rectified by addition of IL-2 (data not shown). were obtained as detailed in the Experimental Proce-
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Figure 2. Generation of sapR78A Mice
(A) Genomic structure of mouse sap gene and construct. The wild-type sap gene is shown at the top. The four exons are indicated. The first
exon contains the initiating ATG (right-sided arrow), whereas the fourth exon bears the stop codon (left-sided arrow). The R78 codon is in
exon 3. The positions of the KpnI (K) sites and of the probe used for screening recombinants by Southern blotting are also indicated. The
construct used for homologous recombination (second from the top) contains a neo-tk cassette flanked by two loxP sites. The left arm is 2.2
kilobases (kb) long, whereas the right arm, which contains exon 3 where the R78 codon is mutated to an alanine codon, is 2.9 kb. Introduction
of the R78A mutation creates an NruI site. The floxed and Cre recombinase-deleted sapR78A alleles are depicted as the two lower schematics.
The positions of the oligonucleotides used for PCR-based screening are shown at the bottom.
(B) PCR screening for the sapR78A mutation. Genomic DNA was prepared from mouse tail and amplified by PCR using the oligonucleotides
depicted in Figure 2A. The DNA was then digested or not with NruI and the products were resolved in polyacrylamide gels. In the absence
of NruI, a 210 nucleotide product exists for both wild-type (sap) and sapR78A DNA. In the presence of NruI, wild-type DNA migrates as a single
210 nucleotide fragment, while sapR78A DNA resolves as two products of 120 and 90 nucleotides. DNAs from three female mice (sap/, sapR78A/
and sapR78A/R78A) were analyzed in this experiment.
(C) Levels of SAP protein. The abundance of SAP was studied by immunoblotting of total cell proteins with anti-SAP (first and third panels).
Immunoblots were reprobed with anti- to confirm equal loading (second and fourth panels).
dures. The sapR78A mutation was easily recognized by ined. Since SLAM seems to be the predominant SLAM
family member involved in IL-4 regulation (Wang et al.,digestion of PCR-amplified genomic DNA with NruI (Fig-
ure 2B). This mutation had no effect on the abundance 2004; Veillette, 2004), we focused our attention on this
receptor. To study the ability of SAP R78A to associateof SAP (Figure 2C).
As the sap gene is on the X chromosome, biochemical with SLAM, SLAM was immunoprecipitated from thymo-
cytes using anti-SLAM mAb 12F12, and immunoprecipi-and functional analyses were performed using hemizy-
gous sapR78A males or homozygous sapR78A/R78A females. tates were probed by immunoblotting with anti-SAP
(Figure 3A, first panel). SAP R78A (lane 2) was able toThe two types of mice (termed sapR78A) showed normal
T cell development and unaltered proportions of T cells associate with SLAM to the same extent as wild-type
SAP (lane 1), supporting the idea that R78 is not a criticalin peripheral lymphoid organs. Moreover, they displayed
the same alterations in mature T cell functions (see component of the phosphotyrosine binding fold of the
below). SAP SH2 domain (Chan et al., 2003). Since the SAP SH2
domain has the peculiarity of interacting with SLAM in
a phosphotyrosine-independent manner (Sayos et al.,SAP R78A Binds to SLAM, but Is Unable to Mediate
SLAM Signaling and TH2 Cytokine Regulation 1998), the SLAM-SAP complex formed even in the ab-
sence of SLAM tyrosine phosphorylation (Figure 3B) (LiThe effect of the R78A mutation on the ability of SAP
to bind SLAM-like receptors and recruit FynT was exam- et al., 1999; Latour et al., 2001).
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Figure 3. Biochemical and Functional Impact of sapR78A Mutation
(A) Ability of SAP R78A to associate with SLAM. Thymocytes were lysed, and SLAM was immunoprecipitated using mAb 12F12 (first and
second panels). The presence of associated SAP was revealed by immunoblotting with anti-SAP (first panel). The presence of SLAM was
confirmed by reprobing with a rabbit anti-SLAM serum (second panel). The abundance of SAP (third panel) and FynT (fourth panel) was
assessed by immunoblotting cell lysates with anti-SAP and anti-FynT, respectively.
(B) Ability of SAP R78A to recruit FynT and promote SLAM-dependent protein tyrosine phosphorylation. Thymocytes were stimulated or not
for 5 min at 37C with anti-SLAM and RAR IgG. After SLAM immunoprecipitation, FynT recruitment was ascertained by immunoblotting with
anti-FynT (first panel). Tyrosine phosphorylation of SLAM was assessed by immunoblotting with anti-phosphotyrosine (P.tyr) (second panel).
The presence of SLAM was confirmed by reprobing with anti-SLAM (third panel). Tyrosine phosphorylation of Dok-2 was ascertained by
probing Dok-2 immunoprecipitates with anti-P.tyr (fourth panel), while the abundance of Dok-2 was verified by reprobing with anti-Dok-2 (fifth
panel). Ig(H): heavy chain of Ig.
(C–F) T cell responses in sapR78A mice. CD4 T cells were activated with the indicated concentrations of anti-CD3 or anti-CD3 plus anti-CD28
in the presence of IL-2, or with PMA and ionomycin (PI). Cytokine secretion (C–E) and proliferation (F) were determined as outlined in the
legend of Figure 1.
(G) gata-3 and t-bet RNA induction. CD4 T cells were stimulated for 48 hr with anti-CD3 (3 g ml1 ), anti-CD3 (3 g ml1 ) plus anti-CD28
(1 g ml1 ), or PMA plus ionomycin. All stimulations were done in the presence of IL-2. After RNA isolation, the abundance of gata-3 and
t-bet transcripts was assessed by real-time PCR.
(H–J) Retroviral rescue of IL-4 defect by GATA-3. (H) The IL-4 defect seen in sap mutant T cells is not affected by the retroviral infection
protocol. CD4 T cells were subjected to a mock retroviral transduction. Once the protocol was completed, cells were stimulated with anti-
CD3 or PMA plus ionomycin, and IL-4 production was measured by ELISA. (I and J) Rescue of IL-4 defect by GATA-3. Sorted cells expressing
GFP alone or in combination with GATA-3 were stimulated for 48 hr with anti-CD3 or PMA plus ionomycin. IL-4 production (I) was monitored
by ELISA, while proliferation (J) was assessed by measuring thymidine incorporation. The expression of GATA-3 (inset in [I]) was determined by
immunoblotting of cell lysates with anti-GATA-3 (top). Equal loading was confirmed by immunoblotting with anti-c-Cbl (bottom). Note that the
levels of IL-4 induced after retroviral transduction of GATA-3 in sap mutant T cells were much higher than those observed in nontransduced
wild-type T cells (seen in Figure 3H). This is presumably because the levels of GATA-3 induced by retroviral transduction of GATA-3 were
much higher, in comparison to those reached in non-transduced activated wild-type cells.
Next, the ability of SAP R78A to couple SLAM to FynT Like SAP deficiency (lanes 5 and 6), mutation of R78
(lanes 3 and 4) abolished the capacity of SLAM to associ-was examined (Figure 3B). Thymocytes were stimulated
or not with anti-SLAM, and the ability of SLAM to interact ate with FynT. The impact of the R78A mutation on
SLAM-induced tyrosine phosphorylation events waswith FynT was ascertained by immunoblotting of anti-
SLAM immunoprecipitates with anti-FynT (first panel). also tested (second panel). The R78A mutation elimi-
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nated both baseline (lane 3) and anti-SLAM-induced propagated for another 48 hour period with IL-2. In the
absence of retroviral transduction, these manipulations(lane 4) tyrosine phosphorylation of SLAM. A similar de-
fect was seen in sap T cells (lanes 5 and 6) (Chan et did not alter the IL-4 defect in sap and sapR78A T cells
(Figure 3H). However, after retroviral transduction (Fig-al., 2003). Likewise, the R78A substitution (fourth panel,
lanes 3 and 4) eliminated the ability of anti-SLAM to ure 3I), expression of GATA-3, but not GFP alone, in-
duced prominent IL-4 secretion in sap and sapR78Astimulate tyrosine phosphorylation of the adaptor Dok-2,
a downstream target of SLAM signaling (Latour et al., T cells. This difference was not caused by an increase
in cell proliferation (Figure 3J; data not shown). Therefore,2001, 2003). Thus, the R78A mutation preserved the
ability of SAP to interact physically with SLAM, while decreased gata-3 induction may be involved in the TH2
defect seen in sap mutant T cells.eliminating its capacity to recruit FynT and promote
SLAM-induced protein tyrosine phosphorylation.
Then, we assessed whether SAP R78A was able to Defect in IgE Production in sapR78A Mice
promote TH2 cytokine production (Figures 3C–3F). CD4 sap mice have low levels of serum IgE (Wu et al., 2001;
T cells from sapR78A, sap , and sap mice were triggered Czar et al., 2001). While the basis of this deficit is not
with anti-CD3, anti-CD3 and anti-CD28, or PMA plus clearly established, it may result at least in part from
ionomycin, and the production of cytokines (IFN-, IL-4, the reduced production of IL-4 and IL-13 by CD4
and IL-13), as well as T cell proliferation, was deter- T cells. These cytokines are critical for T-cell-dependent
mined. sapR78A T cells exhibited no reduction of IFN- B cell maturation and production of antibodies, in partic-
production (Figure 3C) or proliferation (Figure 3F). How- ular IgE (Nelms et al., 1999; Finkelman et al., 1990). This
ever, like sap T cells, they demonstrated a markedly notion was also supported by the finding that, in a viral
reduced production of IL-4 (Figure 3D) and IL-13 (Figure infection model, adoptive transfer of sap CD4 T cells
3E), in response to anti-CD3 or anti-CD3 plus anti-CD28. conferred antibody production defects in a reconstitu-
Surprisingly, defects in IL-4 and IL-13 were also seen ted host (Crotty et al., 2003).
in cells stimulated with PMA plus ionomycin (Figures Given these observations, we ascertained the rele-
3D and 3E). Similarly defective responses to PMA plus vance of the SAP-FynT interaction in vivo by measuring
ionomycin were noted in fyn/ T cells (Supplemental IgE levels in sapR78A, sap, and sap mice (Figures 4A–
Figure S1 available at above URL). 4C). sap mice demonstrated appreciable IgE produc-
While the R78A mutation compromised the ability of tion, especially after immunization with ovalbumin (OVA)
SAP to enhance TH2 cytokine secretion, slightly greater (Figures 4A–4C). This response was maximal after 14
amounts of IL-4 (Figure 3D) and IL-13 (Figure 3E) were days, and was promptly reinduced following a boost
consistently released by activated sapR78A T cells, in immunization (Figures 4A and 4B). By comparison, sap
comparison to sap T cells. As will be discussed, this animals had little or no IgE, even after boost immuniza-
finding suggests that a minor, possibly FynT-indepen- tion. A severe IgE deficit was also observed in sapR78A
dent mechanism contributes to the capacity of SAP to mice, although, in keeping with the results of IL-4 and
regulate TH2 cytokines. IL-13 production, IgE levels were slightly higher than
those in sap mice. These results were reproduced in
three experiments and with at least seven mice in eachDefects in gata-3 Induction Caused by Mutations
group (data not shown). Contrary to the reduction ofin the SAP-FynT Pathway
IgE, the abundance of IgG1 (Figure 4D) was normal orTranscription factor GATA-3 is critical for IL-4 and IL-
minimally affected in sap and sapR78A mice, implying13 production by activated T cells (Murphy and Reiner,
that the SAP-dependent Ig deficit did not affect all Ig2002; Grogan and Locksley, 2002). To assess whether
subclasses. This may relate to the observation that IL-4defects in the SAP-FynT pathway influenced GATA-3
is more critical for IgE than IgG1 synthesis in vivo (Kopfinduction, CD4 T cells from wild-type, sap, sapR78A,
et al., 1993; Kuhn et al., 1991).and fyn/ mice were stimulated with anti-CD3, anti-
IgE levels were also examined in fyn/ mice (FigureCD3 and anti-CD28, or PMA plus ionomycin, and the
4C). Like sap mice and sapR78A mice, mice devoid ofpresence of gata-3 RNA was monitored by real-time
FynT had dramatically reduced levels of IgE. However,PCR (Figure 3G). gata-3 RNA was induced in wild-type
IgG1 levels were essentially normal (Figure 4D). WhileT cells treated with any of these activating stimuli. How-
the interpretation of the IgE defect in fyn/ mice isever, this response was nearly absent in sap, sapR78A,
complicated by the fact that these animals have globaland fyn/ T cells. Such a result was observed in three
T cell signaling defects, this finding supported the ideaexperiments (data not shown). In comparison, levels of
that SAP is linked to FynT in the regulation of IgE produc-t-bet, which is implicated in TH1 regulation (Murphy and
tion in vivo.Reiner, 2002; Grogan and Locksley, 2002), were main-
tained.
To ascertain whether the gata-3 defect might contrib- Functional Deficits in Memory-Type and Naive CD4
T Cells Contribute to the TH2 Defect Causedute to the IL-4 deficit in sap and sapR78A T cells, a
retroviral rescue experiment was performed (Figures by Mutations in the SAP-FynT Pathway
The observation that the IL-4 and IL-13 defects in T cells3H–3J). CD4 T cells were stimulated with anti-CD3 plus
anti-CD28 and IL-2, in the presence of anti-IL-4 and anti- from sap, sapR78A, and fyn/ mice were seen in cells
stimulated with PMA plus ionomycin raised two possibil-IFN- to prevent polarization. After 36 hr, cells were
infected with retroviruses encoding green fluorescent ities. First, SAP and SAP-associated FynT may partici-
pate in distal T cell signaling events, occurring after theprotein (GFP) alone or in combination with GATA-3. After
an additional 48 hr, GFP-positive cells were sorted and induction of overall protein tyrosine phosphorylation by
Immunity
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Figure 4. In Vivo Antibody Production in
sapR78A and fyn/ Mice
(A) IgE levels in sapR78A and sap mice. Mice
were immunized with ovalbumin and com-
plete Freund adjuvant (arrow on the left). A
boost with ovalbumin and incomplete Freund
adjuvant was given at day 28 (arrow on the
right). At the indicated times after immuniza-
tion, serum was obtained and total IgE was
determined by ELISA. “Day 0” corresponds
to nonimmunized animals. The results shown
are for individual mice. This experiment was
repeated three times (data not shown; see
Figure 4C for results of another experiment).
(B) Average values of serum IgE. The average
value of total serum IgE for each group of
mice in the experiment of Figure 4A was de-
termined at the indicated times. Standard de-
viations are shown.
(C) IgE levels in sapR78A, sap and fyn/ mice. Mice were immunized as detailed for Figure 4A. Serum IgE was measured prior (day 0) and
after (day 14) immunization. Results for individual mice are shown.
(D) IgG1 levels in sapR78A, sap and fyn/ mice. Ovalbumin-specific serum IgG1 was measured in the mice from the experiment depicted in
Figure 4C. Only the values observed after immunization (day 14) are shown. No ovalbumin-specific IgG1 was detected prior to immunization
(data not shown).
TCR stimulation and after activation of the presumed We also ascertained whether the IL-4 defect was pres-
ent in naive CD4 T cells (Figure 5C). Naive cells weretargets of PMA plus ionomycin, i.e., protein kinase Cs
purified by negative selection as detailed above. Greater(PKCs) and calcium fluxes (Weiss and Littman, 1994;
than 99.5% of cells obtained were CD44loCD62Lhi (left-van Leeuwen and Samelson, 1999; Latour and Veillette,
side panels). Cells were then stimulated for 72 hr with2001). Second, SAP and SAP-associated FynT may be
anti-CD3 or PMA plus ionomycin, and IL-4 secretion wasneeded for the development and/or maintenance of one
monitored (right-side panel). Although the production ofor more T cell subpopulation(s) involved in TH2 priming.
IL-4 by naive T cells was much lower than that observedTo address these issues, we first determined the rela-
in memory-type T cells, an IL-4 deficit clearly existed intive production of IL-4 by naive (CD44loCD62Lhi) and
cells from sap, sapR78A, and fyn/ mice. Thus, the TH2memory-type (CD44hiCD62Llo) T cells. The CD4 T cells
defect of sap and fyn mutant T cells was found not onlyused in our experiments contained conventional naive
in memory-type T cells, but also in naive T cells.and memory-type T cells, and a small amount (1%–2%)
of NK1.1CD3 natural killer (NK)-T cells (data not
shown) (Woodland and Dutton, 2003; Brigl and Brenner, Lack of SLAM Expression Reproduces the CD4
T Cell Defects Induced by Mutations2004). Hence, cells depleted of NK-T cells were first
obtained, and then subjected or not to removal of mem- in the SAP-FynT Pathway
Considering the report that slam/ T cells displayed anory-type cells using anti-CD44 (Figure 5A). Staining with
anti-CD44 showed that, in the absence of depleting anti- IL-4 defect in response to anti-CD3 (Wang et al., 2004),
it seemed reasonable to propose that SLAM, a self-CD44, approximately 10% of cells were CD44hi memory-
type T cells. However, when anti-CD44 was added to associating receptor, might be the predominant trigger
of the SAP-FynT pathway during TH2 priming. To developthe depletion cocktail, no CD44hi T cells remained. The
two cell preparations were then stimulated with anti- this further, we first tested the impact of anti-CD3 or
PMA plus ionomycin on the expression of SLAM usingCD3, anti-CD3 and anti-CD28, or PMA plus ionomycin,
and IL-4 secretion was determined. Depletion of mem- purified splenic CD4 T cells (Figure 6A). As reported
(Castro et al., 1999; Howie et al., 2002), SLAM expressionory T cells markedly reduced IL-4 production by CD4
T cells. The remaining cells, i.e., naive CD4 T cells, was low on resting mature T cells. This was in contrast
to thymocytes, which expressed high levels of SLAMproduced only 2%–5% of the IL-4 released in prepara-
tions containing memory-type T cells. (Figure 6C) (Castro et al., 1999). SLAM expression was
strongly induced on splenic T cells within 12 hr of anti-To examine if mutations in the SAP-FynT pathway
reduced TH2 cytokine production by affecting the pres- CD3 stimulation (left panel). This upregulation was ob-
served on 100% of the cells, implying that it affectedence of memory-type T cells, NK-T-cell-depleted CD4
T cells from the various mice were stained with anti- naive and memory-type T cells. Interestingly, expression
of SLAM was also rapidly induced by PMA plus iono-CD44 and anti-CD62L (Figure 5B). There was no obvious
difference in the abundance of memory-type (CD44hi mycin (middle panel). With either stimulation, the in-
creased SLAM expression persisted for at least 48 hrCD62Llo) T cells between wild-type, sap, sapR78A, and
fyn/ mice (left-side panels). Nevertheless, an IL-4 de- (right panel). Contrary to SLAM, expression of SAP (Fig-
ure 6B) was high in resting CD4 T cells (lane 1). More-fect was clearly seen in NK-T-cell-depleted cells from
sap, sapR78A, and fyn/ mice (right-side panel). There- over, it was reduced by treatment with anti-CD3 (lanes
2, 4, and 6) or PMA plus ionomycin (lanes 3, 5, and 7),fore, a functional deficit, rather than the absence, of
memory-type CD4 T cells seemed involved in the TH2 although some expression was maintained throughout
the course of the stimulation. No change in FynT expres-dysfunctions caused by mutations in the SAP-FynT
pathway. sion was seen under these conditions (data not shown).
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Figure 5. Characterization of T Cells Responsible for SAP-FynT-Dependent TH2 Cytokine Regulation
(A) Differential T cell depletion. NK-T cell-depleted CD4 T cells were purified from the spleen of C57BL/6 mice in the absence (first and
second panels) or the presence (third and fourth panels) of depleting anti-CD44 to remove memory-type T cells. Anti-CD49b, which removes
NK cells, was also added during all purifications. Purified cells were stained with anti-CD44 and analyzed by flow cytometry (first and third
panels). IL-4 production was determined by ELISA (second and fourth panels). Anti-CD3 was used at a concentration of 3 g ml1, and all
stimulations were done in the presence of IL-2.
(B) Detection and function of memory-type CD4 T cells. NK-T cell-depleted CD4 T cells were purified using the standard purification
cocktail supplemented with anti-NK1.1 and anti-CD49b. Purified cells were stained with anti-CD44 and anti-CD62L to detect memory-type
(CD44hiCD62Llo) and naive (CD44loCD62Lhi) CD4 T cells (first, second, third, and fourth panels from the left). The percentages of memory-type
T cells are shown at the bottom right of each dot plot. Production of IL-4 is shown in the last panel on the right. Anti-CD3 was used as detailed
for Figure 5A.
(C) Function of naive CD4 T cells. Naive CD4 T cells were purified by negative selection using the standard purification cocktail supplemented
with anti-CD44 and anti-CD49b. To assess purity, cells were stained with anti-CD44 and anti-CD62L (first, second, third, and fourth panels
from the left), as detailed for Figure 5B. Production of IL-4 is shown in the last panel on the right. Anti-CD3 was used as detailed for Figure
5A, except that cells were stimulated for 72 hr.
These results were compatible with the idea that in- T cells (Supplemental Figure S2, available online at http://
www.immunity.com/cgi/content/full/21/5/707/DC1/).duction of SLAM in response to TCR stimulation or PMA
plus ionomycin might be needed for activation of the These findings supported the idea that SLAM is the
major trigger of the SAP-FynT cascade needed for TH2SAP-FynT pathway and upregulation of TH2 cytokine
production. To confirm this notion, CD4 T cells were cytokine production in vitro.
obtained from slam/ mice (Figure 6C) and subjected
to several analyses (Figures 6D–6H). First, staining with Discussion
anti-CD44 and anti-CD62L showed that SLAM deficiency
had no impact on the abundance of memory-type (CD44hi Herein, we examined the role of FynT in SAP-mediated
functions in T cells. We found that the ability of TCRCD62Llo) T cells (Figure 6D), as documented above for
mice with mutations in the SAP-FynT cascade. Second, stimulation to trigger TH1 and TH2 cytokines in CD4
T cells, as well as induce IL-2 secretion and proliferation,functional studies demonstrated that lack of SLAM caused
pronounced defects in IL-4 (Figure 6E) and IL-13 (Figure was markedly compromised in fyn/ T cells. This was
presumably because FynT is required in part to couple6F) in response to anti-CD3 or PMA plus ionomycin,
similar to those caused by mutations in the SAP-FynT TCR to the proximal tyrosine phosphorylation cascade
in T cells (Appleby et al., 1992; Stein et al., 1992). Itpathway. In contrast, little or no effect was seen on T cell
proliferation (Figure 6H). Furthermore, whereas a small is unlikely that SAP is involved in this aspect of FynT
function, as TCR-triggered IFN- production, IL-2 secre-decrease in IFN- release was noted in this assay (Figure
6G), this was not observed in other experiments (data tion, and proliferation were not reduced in sap T cells.
The observation that the TH2 defect encountered innot shown). Similar results were obtained with NK-T-cell-
depleted CD4 T cells (data not shown) or naive CD4 sap T cells was also seen in fyn/ T cells supported the
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Figure 6. Evidence Supporting the Involvement of SLAM in SAP-FynT-Dependent TH2 Priming
(A) Induction of SLAM expression. CD4 T cells from C57BL/6 mice were stimulated for 12 hr with anti-CD3 alone (3 g ml1 ) (left panel) or
PMA plus ionomycin (middle panel). SLAM expression was determined by flow cytometry. The expression of SLAM in untreated cells
corresponds to “0 h.” Nonspecific staining is shown as the filled curve. The impact of longer stimulations (24 hr or 48 hr) is shown in the right
panel, where levels of SLAM are represented using the mean fluorescence value.
(B) SAP expression. Cells were stimulated as detailed for Figure 6A. SAP expression was measured by immunoblotting of total cell proteins
with anti-SAP. 3: anti-CD3; P: PMA plus ionomycin.
(C–H) Immune defects in slam/ mice. (C) Expression of SLAM. SLAM expression in slam/ and slam/ mice was determined by flow
cytometry of thymocytes using anti-SLAM (left and middle panels). Thin line: secondary reagent alone; thick line: anti-SLAM plus secondary
reagent. SLAM expression was also assessed by immunoblotting of total cellular proteins from thymus with anti-SLAM (right panel). (D)
Detection of memory-type CD4 T cells in slam/ mice. CD4 T cells were purified using the standard purification cocktail supplemented
with anti-NK1.1 and anti-CD49b. Cells were stained with anti-CD44 and anti-CD62L. The percentages of memory-type T cells are shown at
the bottom right of each dot plot. (E–H) CD4 T cells were stimulated with anti-CD3 alone or PMA plus ionomycin (PI), in the presence of
IL-2. Cytokine production and proliferation were assessed as for Figure 1.
idea that SAP was acting through FynT in TH2 priming. Obviously, one cannot formally exclude that the R78A
mutation also abrogated another as yet unknown func-However, since the deficits in fyn/ T cells were more
severe than those in sap T cells, this interpretation was tion of SAP. This possibility is unlikely, however, as no
other SH3 domain-containing molecule was found totenuous. It was conceivable that SAP and FynT were
regulating TH2 cytokines by acting in separate signaling interact with the R78-based motif of SAP (Latour et al.,
2003). Furthermore, based on crystallographic studies,cascades or distinct cell types. Therefore, we created
a mouse strain in which the FynT binding site of SAP mutation of R78 is not expected to alter the capacity of
SAP to interact with tyrosine phosphorylated SLAM-was mutated in the germ line. The mutation did not affect
the levels of SAP or the aptitude of SAP to associate with like receptors (Chan et al., 2003). This last idea is also
supported by our finding that the ability of SAP to associ-SLAM, a receptor involved in TH2 regulation. However, it
eliminated the ability of SAP to recruit FynT and to pro- ate with SLAM and its relative 2B4 was not compromised
by the R78A mutation (Chen et al., 2004; Latour et al.,mote SLAM-mediated protein tyrosine phosphorylation.
Our results showed that the SAP R78A substitution 2003).
Although the ability of SAP to promote TH2 cytokinereplicated the TH2 defects caused by lack of SAP expres-
sion. sapR78A CD4T cells demonstrated a marked reduc- and IgE production was markedly reduced by the R78A
mutation, a small residual function (5%–10% of thattion of IL-4 and IL-13 release in response to anti-CD3
or anti-CD3 plus anti-CD28. Moreover, the ability of mice of wild-type SAP) was observed. It is plausible that this
residual activity reflected a remaining capacity of SAPto produce IgE, a response dependent on IL-4 and, to
a lesser extent, IL-13, was severely attenuated in sapR78A R78A to bind FynT. This seems improbable, though, as
R78 is the epicenter of the FynT binding site in SAPmice. A similar defect was seen in fyn/ mice. Hence,
these results provided strong support for the concept (Chan et al., 2003; Latour et al., 2003). Moreover, muta-
tion of R78 abrogated all complex formation betweenthat SAP regulates TH2 cytokines by binding FynT.
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SAP and FynT, including in vitro binding assays using
recombinant FynT SH3 domains (Latour et al., 2003). It
appears more likely that SAP R78A utilized an alterna-
tive, albeit less efficient, mechanism for TH2 cytokine
regulation.
Among conventional CD4 T cells, the cells primarily
responsible for SAP-FynT-dependent TH2 cytokine pro-
duction in vitro were memory-type T cells. A functional,
rather than developmental, defect in these cells seemed
responsible for most of the compromised TH2 activity
caused by mutations in the SAP-FynT pathway. Al-
though the amount of TH2 cytokines produced by naive
CD4 T cells was much lower than that seen in memory-
type cells, a defect in IL-4 production was also observed
Figure 7. The SLAM-SAP-FynT Cascade in TH2 Cytokine Regulationin naive cells. Obviously, future studies are needed to
Model of activation of SLAM-SAP-FynT pathway during T cell activa-
assess the contribution of these two cell types to the tion. Resting T cells express SAP and FynT, but express little SLAM.
T cell-dependent abnormalities in B cell functions seen In response to TCR engagement by antigen/MHC (or the pharmaco-
in sap/ mice (Wu et al., 2001; Czar et al., 2001; Crotty logical agonists PMA and ionomycin), SLAM expression is rapidly
induced. This triggers engagement of SLAM by SLAM moleculeset al., 2003). While not studied here, it is also conceivable
expressed on dendritic cells (DCs) or, alternatively, other T cellsthat NK-T cells participate in SAP-FynT-dependent TH2
(not shown). This induces binding of SAP to SLAM, recruitmentregulation. Defects in NK-T cell development exist in
and activation of FynT, and tyrosine phosphorylation of SLAM andfyn/ mice and, possibly, sap/ mice (Gadue et al.,
possible downstream targets such as SHIP-1 and Dok-related adap-
1999; Eberl et al., 1999). However, we recently found tors (not shown). This signal causes upregulation of GATA-3 and
that there is little correlation between the abundance of production of TH2 cytokines like IL-4 and IL-13. In the absence of
SLAM, SAP or FynT, or when SAP is unable to bind FynT (sapR78ANK-T cells and TH2 cytokine production in mice with
mutation), this pathway is not activated, leading to TH2 defects.mutations in the SAP-FynT cascade (our unpublished
MHC: major histocompatibility complex.data).
The finding that slam/ CD4 T cells exhibited TH2
defects implied that altered SLAM function could explain we reported that SLAM engagement in the presence of
the TH2 cytokine dysfunction caused by mutations in the SAP results in tyrosine phosphorylation and/or recruit-
SAP-FynT pathway (Wang et al., 2004) (this report). This ment of the 5 lipid phosphatase SHIP-1, the adaptors
notion is in agreement with the finding that SLAM ex- Dok-1, Dok-2 and Shc, and the negative regulator of
pression was strongly and rapidly induced on CD4 Ras, Ras-GTPase-activating protein (GAP) (Latour et al.,
T cells treated with anti-CD3 or PMA plus ionomycin. 2001). These events are eliminated by the SAP R78A
Since SLAM is a self-ligand, this induction would pre- mutation or by ablation of FynT expression, implying
sumably recruit SAP to the membrane, recruit and acti- that they are true components of the SAP-FynT pathway
vate FynT in the vicinity of SLAM, and promote TH2 (Latour et al., 2001, 2003) (this report). It should also
cytokine production (Figure 7). In the absence of SLAM, be remembered that mutations in the SLAM-SAP-FynT
SAP, or FynT, or when SAP is unable to bind FynT, this pathway interfered with TH2 cytokine production not only
cascade would be defective, leading to the common in response to TCR stimulation, but also following expo-
TH2 defect described herein. sure to PMA and ionomycin. Therefore, the effectors of
Interestingly, we found that SLAM induction by PMA the SLAM-SAP-FynT pathway are probably not acting
plus ionomycin was caused by ionomycin rather than proximally in the TCR signaling cascade. Rather, their
PMA (Supplemental Figure S3A). This implied that SLAM
influence would likely take place after TCR-induced pro-
expression in T cells may be triggered by the calcium-
tein tyrosine phosphorylation and before triggering of
calcineurin pathway instead of the protein kinase C
TH2 regulator GATA-3 (Figure 7).pathway. This notion is consistent with the observation
Our data provide firm genetic evidence that SAP isthat SLAM was also induced by thapsigargin, an agent
involved in the positive regulation of TH2-mediated func-causing an influx of calcium through the plasma mem-
tions in T cells as a result of its capacity to associate withbrane by depleting endoplasmic reticulum stores (Sup-
and activate FynT. They also unravel that, in addition toplemental Figure S3B). Moreover, it is supported by the
coupling TCR stimulation to the proximal protein tyro-finding that SLAM induction by anti-CD3 or ionomycin
sine phosphorylation cascade in T cells, FynT plays awas blocked by cyclosporin A, a calcineurin inhibitor
previously unappreciated role in TH2 cytokine regulation.(Supplemental Figure S3C). Since the induction of SLAM
Since 30%–50% of patients with XLP and XLP-like ill-expression on activated T cells occurs at the transcrip-
nesses do not carry sap mutations (Latour and Veillette,tional level (Cocks et al., 1995; Wang et al., 2001), it is
2003; Engel et al., 2003), the possibility that some oflikely that one or more transcription factors activated
these individuals have mutations in other componentsby the calcium-calcineurin pathway, such as nuclear
of the SAP-FynT pathway deserves consideration.factor of activated T cells (NFAT) and myocyte enhancer
factor (MEF)-2 (Kuo and Leiden, 1999), regulate SLAM
Experimental Procedures
expression.
The precise mechanism linking the SLAM-SAP-FynT Mice
complex to transcriptional activation of GATA-3 and TH2 sap and fyn/ mice were described elsewhere (Czar et al., 2001;
Stein et al., 1992). They were backcrossed up to 5 generations ontocytokine production remains to be identified. Previously,
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a C57BL/6 background, and the phenotypes described herein were Depletion of NK-T cells was achieved by adding anti-NK1.1. Re-
moval of NK-T cells was confirmed by staining with anti-NK1.1 andmaintained throughout the backcrossing. As the sap gene is X
linked, wild-type mice (denoted as sap) were either / or , anti-CD3 (data not shown). To measure cytokine production or pro-
liferation, T cells were stimulated with the indicated concentrationswhereas sap mice were either / or . Mice lacking SLAM (slam/)
were generated by replacing the exon 2 of the slam gene with a of anti-CD3 coated on plastic, with or without soluble anti-CD28
(1 g ml1 ) and IL-2 (100 U ml1 ). In some cases, cells were stimu-neo cassette (O.N. and Y.Y., unpublished data). These mice were
found to lack detectable SLAM by flow cytometry and immunoblot, lated with PMA (100 ng ml1 ) plus ionomycin (1 M). After 48–72
hr, cytokine production was measured by ELISA, according to theand to exhibit normal T cell development and mature T cell popula-
tions (Figures 6C and 6D; data not shown). To create a mouse in protocols of the manufacturer (R&D Systems, Minneapolis, MN).
Proliferation was assayed by labeling for 6 hr with tritiated thymidinewhich R78 of SAP was mutated to alanine (sapR78A), the sap gene
was cloned from a 129/Sv genomic library. After subcloning the and measuring thymidine incorporation. All assays were done in
duplicate and repeated at least five times.relevant genomic fragments, the R78 codon (CGG) located in the
3 fragment was replaced by an alanine codon (GCG) by PCR. The
resulting fragment was sequenced to identify the mutation and en-
Expression of gata-3 and t-betsure that no unwanted mutation had been introduced. The 5 and
Purified CD4 T cells were stimulated with anti-CD3, anti-CD3 and3 genomic fragments were cloned in the vector pcDNAII-loxP-frt
anti-CD28, or PMA plus ionomycin, as detailed above. After 48 hr,(Figure 2A). After linearizing, the DNA was electroporated into the
cells were harvested and processed for RNA extraction accordingES cell line R1, and transfected cells were selected with G418.
to standard protocols. Expression of gata-3 and t-bet RNA wasIndividual clones were screened by Southern blotting using KpnI,
determined by real-time PCR, using the oligonucleotides 5-CTTATand positive clones were injected into blastocysts. Generation of
CAAGCCCAAGCGAAG-3 and 5-CAGGGATGACATGTGTCTGG-3chimeras and germ line transmission of the mutation were achieved
for gata-3, and 5-AATCGACAACAACCCCTTTG-3 and 5-AACTGTaccording to standard procedures. Deletion of the loxP-flanked neo-
GTTCCCGAGGTGTC-3 for t-bet. RNA levels were standardized bytk cassette was performed by crossing mice with a transgenic
parallel measurements of S16 RNA. All assays were specific for themouse expressing the Cre recombinase under the control of an EIIa
indicated transcription factors and were done under linear condi-promoter (provided by P. Love, NIH, Bethesda, MD) (Sommers et
tions (data not shown).al., 2002). Mice with an appropriately recombined sapR78A allele were
identified and bred with C57BL/6 mice to eliminate the cre trans-
gene. In subsequent generations, mice carrying the sapR78A mutation
Retroviral Infection
were identified by PCR amplification of genomic DNA and digestion
Purified CD4 T cells were activated with anti-CD3 (3 g ml1 ) plus
with NruI. The presence of the sapR78A mutation introduces an NruI
anti-CD28 (1 g ml1 ), in the presence of IL-2 (100 U ml1 ), anti-
site. Mice were backcrossed with C57BL/6 for at least three genera-
IL-4 (10 g ml1 ), and anti-IFN- (10 g ml1 ). After 36 hr, they were
tions prior to experiments. Wild-type littermates were used as con-
infected twice with retroviral supernatant from Phoenix packaging
trols.
cells transfected with empty pMIG (expressing GFP alone) or pMIG-
mGATA-3 (encoding GFP and mouse GATA-3), in the presence of
Antibodies and Reagents polybrene (5 g ml1). After a rest period of 48 hr in IL-2-containing
Antibodies against SAP, SLAM, FynT, Dok-2, phosphotyrosine, and medium, GFP-positive cells were sorted (Mo-Flo, Cytomation, Fort
Lck were described (Latour et al., 2001; Davidson et al., 1992). Collins, CO). Following an additional 48 hr, cells were stimulated for
Mouse anti-GATA-3 mAb HG3-31 was purchased from Santa Cruz 2 days with anti-CD3 alone or PMA plus ionomycin. IL-4 release
Biotechnology Inc., Santa Cruz, CA. Purified and biotinylated rat and proliferation were assayed as outlined above.
anti-SLAM mAb 12F12, anti-CD3 mAb 145-2C11, anti-CD28 mAb
37.51, and anti-zeta mAb H146 were prepared in our laboratory.
Induction of SLAM ExpressionBiotinylated anti-CD69 mAb H1.2F3, biotinylated or phycoerythrin
CD4 T cells from normal C57BL/6 mice were stimulated for 18 hr(PE)-conjugated anti-NK1.1 mAb PK136, biotinylated or PE-conju-
with PMA (100 ng ml1 ), ionomycin (1 M), PMA plus ionomycin, orgated anti-CD44 mAb KM114, biotinylated anti-CD49b mAb DX-5,
thapsigargin (0.11 M). In some experiments, cells were stimulatedfluorescein isothiocyanate (FITC)-conjugated anti-CD3 mAb 145-
for 18 hr with anti-CD3 (3 g ml1 ) or ionomycin, in the presence2C11, and FITC-conjugated anti-CD62L mAb MEL-14 were pur-
or the absence of cyclosporin A (300 ng ml1 ). Expression of SLAMchased from BD Biosciences, Mississauga, Ontario, Canada. Quan-
or CD69 was measured by flow cytometry.tum Red-coupled streptavidin, PMA, ionomycin, ovalbumin (grade
VI), Freund adjuvants, thapsigargin, and cyclosporin A were ob-
tained from Sigma-Aldrich, Oakville, Ontario, Canada.
IgE Production
Groups of two to three 7- to 12-week-old mice were injected subcu-
Cell Stimulation, Immunoprecipitations, and Immunoblots
taneously with 200 g of ovalbumin (4 mg ml1; in phosphate-buf-
Thymocytes (6.25  107 cells ml1 ) were incubated for 30 min on ice
fered saline) plus 50 l of complete Freund adjuvant. In some cases,
with mAb 12F12 (25 g ml1). After washing unbound antibodies,
mice were boosted by subcutaneous injection of the same quantity
cells were stimulated for 5 min at 37C with rabbit anti-rat (RAR) IgG.
of ovalbumin, mixed with incomplete adjuvant. After immunization,
Unstimulated cells were treated in the same manner, except that they
mice were bled on a weekly basis. Total serum IgE, ovalbumin-
were kept at 4C. After lysis in 2 TNE buffer (1 TNE: 50 mM Tris
specific IgE and ovalbumin-specific IgG1 were measured by ELISA,[pH 8.0], 1% Nonidet P-40, and 2 mM EDTA) supplemented with
according to standard protocols.
protease and phosphatase inhibitors, SLAM was immunoprecipi-
tated by addition of formalin-fixed Staphylococcus aureus (Calbio-
chem-Novobiochem Co., San Diego, CA). Dok-2 was immunoprecipi- Acknowledgments
tated from precleared cell lysates using affinity-purified anti-Dok-2.
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